Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Emerging Infectious Disease Diagnostics Market - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.
The Asia-Pacific emerging infectious disease diagnostics market was valued at $4.41 billion in 2022 and is expected to reach $10.83 billion by 2033, growing at a CAGR of 8.65% between 2023 and 2033. A number of factors are driving the growing infectious disease diagnostics market's expansion in the Asia-Pacific area.
The financial burden of infectious diseases, support from governments in the form of partnerships and financing, the growing demand for rapid and thorough testing, and developments in molecular diagnostics technology are some of these causes. 
In the APAC market, diagnostics for infectious diseases comprise a variety of approaches and procedures used to identify and find infectious agents in people who may be infected. These diagnostics are essential for prompt treatment decisions, accurate disease diagnosis, and the execution of public health initiatives.
Microbiological culture is one of the basic methods used in the diagnosis of infectious diseases. To isolate and identify certain pathogens, patient specimens are cultured on specialized growth media. Healthcare professionals can identify the causing organism and evaluate its antibiotic susceptibility by doing this.
Molecular diagnostics is a key strategy in the APAC industry. This entails detecting the genetic makeup of the infectious pathogen using methods like nucleic acid amplification tests (NAATs) and polymerase chain reaction (PCR). This enables the highly sensitive and specific identification of pathogens, even at low concentrations.
Market Drivers and Challenges
The growth of the market in Asia-Pacific is driven by factors such as the high incidence of infectious diseases, the emergence of pathogen-related outbreaks, and increasing demand for point-of-care diagnostics.
However, factors such as the erratic trend in infectious disease outbreaks and the poor reimbursement of molecular diagnostic tests are expected to hinder the growth of the market in Asia-Pacific.
Drivers
- Economic Burden of Infectious Diseases
- Government Support to Advance Research and Facilitate Early Diagnosis of Infectious Diseases Through Funding and Collaboration
- Increasing Demand for Point-of-Care (POC) and Syndromic Testing
- Technological Advancements in Molecular Diagnostics
- Isothermal Nucleic Acid Amplification Techniques (INAATs)
- Digital PCR
- CRISPR Technologies
Restraints
- Poor Reimbursement for Molecular Diagnostic Tests for Infectious Diseases
- Erratic Trend in Infectious Disease Epidemic Outbreaks Globally
- Lack of an Established Framework for NGS-based Tests for Infectious Diseases
Opportunities
- Potential of Molecular Diagnostic Tests in Low-Resource Settings
- Potential of Rapid Point-of-Care Tests in Managing Antimicrobial Resistance
Key Report Highlights
- Analysis of business drivers and challenges of the Asia-Pacific Emerging Infectious Disease Diagnostics Market
- Detailed analysis of Emerging Infectious Disease Diagnostics Market for China, Japan, India, South Korea and Australia
- Segmentation by application, technology, type of infection, disease type, and end user provided in the report
Market Segmentation:
Segmentation by Application
- Laboratory Testing
- Point-of-Care Testing
Segmentation by Technology
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- Next-Generation Sequencing (NGS)
- Immunodiagnostics
- Other Technologies
Segmentation by Type of Infection
- Bacterial
- Viral
- Fungal
- Other Infections
Segmentation by Disease Type
- Respiratory Infections
- Sexually Transmitted Infections (STIs)
- Gastrointestinal Infections
- Other Infections
Segmentation by End User
- Hospitals and Clinics
- Diagnostic Laboratories
- Other End Users
Segmentation 6: by Region
- Asia-Pacific - Japan, China, India, South Korea, Australia, Rest-of-Asia-Pacific
Key Questions Answered in the Report
- What are the major market drivers, challenges, and opportunities in the Asia-Pacific emerging infectious disease diagnostics market?
- What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
- Who are the leading players with significant offerings in the emerging infectious disease diagnostics market?
- What does the supply chain look like for diagnostic tests?
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 116 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value (USD) in 2023 | $4.73 Billion |
| Forecasted Market Value (USD) by 2033 | $10.83 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Asia Pacific |
Key Topics Covered:
1 Markets
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.2 Industry Outlook
1.2.1 Market Overview
1.2.1.1 Timeline of Emerging Technologies for Infectious Disease Diagnostics
1.2.1.2 Advantages and Limitations of Emerging Infectious Disease Diagnostic Technologies
1.2.1.3 Advantages and Limitations of Point-of-Care Emerging Infectious Disease Diagnostics
1.2.1.4 Current Market Landscape of Emerging Infectious Disease Diagnostics
1.2.1.5 Future Potential
1.2.1.5.1 CRISPR
1.2.1.5.2 NGS
1.2.1.5.3 INAAT
1.2.1.5.4 Digital PCR (dPCR)
1.2.2 Patent Analysis
1.2.3 Pipeline Analysis
1.2.4 Impact of COVID-19 on Infectious Disease Diagnostics
1.2.5 Supply Chain Analysis
1.3 Market Dynamics
2 Asia-Pacific
2.1 Asia-Pacific Emerging Infectious Disease Diagnostics Market
3 Markets - Competitive Benchmarking & Company Profiles
3.1 Competitive Landscape
3.1.1 Overview
3.1.2 Corporate Strategies
3.1.2.1 Mergers and Acquisitions
3.1.2.2 Synergistic Activities
3.1.2.3 Business Expansions and Funding
3.1.3 Business Strategies
3.1.3.1 Product Launches/Upgradations/Approvals
3.2 Market Share Analysis
3.3 Emerging Infectious Disease Diagnostics Ecosystem Active Players
3.4 Company Profiles
3.5 Company Snapshots
3.5.1 CrisprBits
3.5.1.1 Company Overview
3.5.1.2 Role of CrisprBits in the Emerging Infectious Disease Diagnostics Market
3.5.1.3 Key Developments
For more information about this report visit https://www.researchandmarkets.com/r/9pi838
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
